Heart Failure With Preserved Ejection Fraction trials recruiting in Pennsylvania

All Heart Failure With Preserved Ejection Fraction trials nationally

Cities in Pennsylvania

Recruiting trials in Pennsylvania

• A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
  NCT07214376 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · Pennsylvania: Mechanicsburg
• A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
  NCT07795814 · Phase: Phase 2 · Ages: 30 Years to 84 Years · Sex: All (male and female) · Pennsylvania: Mechanicsburg, Pittsburgh
• Assessment of CCM in HF With Higher Ejection Fraction
  NCT05064709 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Bryn Mawr, Harrisburg, Hershey, Lancaster
• HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
  NCT05873634 · Phase: Not specified · Ages: 30 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Pennsylvania: Horsham, Pittsburgh
• Matching Perfusion and Metabolic Activity in HFpEF
  NCT04913805 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia
• Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
  NCT06517186 · Phase: Not specified · Ages: 30 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia
• SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial
  NCT05138575 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia
• Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
  NCT02901184 · Phase: Phase 3 · Ages: 50 Years to 99 Years · Sex: All (male and female) · Pennsylvania: Hershey, Philadelphia, Pittsburgh